Breaking News Instant updates and real-time market news.

ALXN

Alexion

$110.79

-2.67 (-2.35%)

07:27
04/12/18
04/12
07:27
04/12/18
07:27

Alexion price target raised to $165 from $156 at Nomura Instinet

Nomura Instinet analyst Christopher Marai raised his price target for Alexion Pharmaceuticals to $165 following the company's acquisition of Wilson Therapeutics. The analyst incorporated WTX101 estimates into his model and keeps a Buy rating on Alexion.

ALXN Alexion
$110.79

-2.67 (-2.35%)

04/11/18
PIPR
04/11/18
NO CHANGE
Target $170
PIPR
Overweight
Alexion acquisition of Wilson 'makes a lot of sense,' says Piper Jaffray
Piper Jaffray analyst Christopher Raymond analyst believes Alexion Pharmaceuticals' acquisition of Wilson Therapeutics "makes a lot of sense." The deal adds an incremental value of $4 per share, according to Raymond's model. The analyst say Wilson's WTX101, an oral, high affinity copper binding agent in a Phase 3 trial for the treatment of Wilson's disease, meets a significant unmet need despite two approved, but marginally effective therapies. More strategically, investors will like the evidence of deal execution from the new management team, Raymond tells investors in a research note. He thinks Alexion shares "are well positioned for recovery" and keeps an Overweight rating on the name with a $170 price target.
04/11/18
JEFF
04/11/18
NO CHANGE
Target $113
JEFF
Hold
Market opportunity for Alexion acquired WTX101 likely limited, says Jefferies
After Alexion announced a deal to buy Wilson Therapeutics for $855M, and thus acquire WTX101, a drug in Phase 3 testing for the orphan condition of Wilson disease, Jefferies analyst Eun Yang said she sees the market opportunity for WTX101 as likely limited unless it shows clear superiority versus the current standard of care. She estimates a fair value of $1 per share for WTX101 and raised her price target on Alexion to $113 from $112 to reflect that estimate. Yang keeps a Hold rating on Alexion.
03/28/18
JPMS
03/28/18
NO CHANGE
JPMS
Overweight
Alexion shares 'significantly undervalued' after pullback, says JPMorgan
JPMorgan analyst Anupam Rama says shares of Alexion Pharmaceuticals are "significantly undervalued" after pulling back 15% since the Phase 3 study data release of ALXN1210 in paroxysmal nocturnal hemoglobinuria naive patients. The analyst sees 50%-60% fundamental upside from current levels and keeps an Overweight rating on the shares.
03/16/18
NOMU
03/16/18
NO CHANGE
Target $156
NOMU
Buy
Alexion price target raised to $156 from $148 at Nomura Instinet
Nomura Instinet analyst Christopher Marai raised his price target for Alexion Pharmaceuticals to $156 saying he views yesterday's Phase III data for ALXN1210 positively. ALXN1210 is is likely to replace Soliris in the clinic broadly, Marai tells investors in a research note. He keeps a Buy rating on Alexion shares.

TODAY'S FREE FLY STORIES

IOVA

Iovance Biotherapeutics

$15.90

0.85 (5.65%)

11:12
08/14/18
08/14
11:12
08/14/18
11:12
Conference/Events
Iovance Biotherapeutics management to meet with Oppenheimer »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Aug

  • 04

    Sep

BA

Boeing

$338.77

0.34 (0.10%)

11:12
08/14/18
08/14
11:12
08/14/18
11:12
Hot Stocks
Boeing reports total of 487 orders through July 31 »

The breakdown is as…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GLPI

Gaming and Leisure Properties

$34.88

0.04 (0.11%)

, AGS

PlayAGS

$30.33

0.16 (0.53%)

11:10
08/14/18
08/14
11:10
08/14/18
11:10
Recommendations
Fly Intel: Today's top analyst calls on Wall Street »

Check out today's…

GLPI

Gaming and Leisure Properties

$34.88

0.04 (0.11%)

AGS

PlayAGS

$30.33

0.16 (0.53%)

VICI

VICI Properties

$20.30

0.215 (1.07%)

LVS

Las Vegas Sands

$67.08

(0.00%)

WYNN

Wynn Resorts

$144.45

-3.55 (-2.40%)

MGP

MGM Growth

$29.47

0.18 (0.61%)

IGT

International Game

$20.41

-0.15 (-0.73%)

SGMS

Scientific Games

$31.45

-0.3 (-0.94%)

CRM

Salesforce

$145.87

1.47 (1.02%)

NLSN

Nielsen

$26.06

1.44 (5.85%)

SQ

Square

$74.40

2.03 (2.81%)

SWCH

Switch

$10.53

-3.43 (-24.57%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Aug

  • 15

    Aug

  • 16

    Aug

  • 16

    Aug

  • 20

    Aug

  • 21

    Aug

  • 28

    Aug

  • 29

    Aug

  • 06

    Sep

  • 07

    Sep

  • 10

    Sep

  • 12

    Sep

  • 19

    Sep

EXEL

Exelixis

$19.90

0.26 (1.32%)

11:10
08/14/18
08/14
11:10
08/14/18
11:10
Conference/Events
Exelixis management to meet with Oppenheimer »

Meeting to be held in San…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Aug

  • 14

    Jan

ECL

Ecolab

$147.03

1.08 (0.74%)

11:07
08/14/18
08/14
11:07
08/14/18
11:07
Conference/Events
Ecolab management to meet with William Blair »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Aug

  • 16

    Aug

  • 05

    Sep

  • 11

    Sep

GE

General Electric

$12.49

0.05 (0.40%)

11:00
08/14/18
08/14
11:00
08/14/18
11:00
Options
GE Bear lays out $1.68M for 66day downside spread »

GE Bear lays out $1.68M…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 27

    Sep

11:00
08/14/18
08/14
11:00
08/14/18
11:00
General news
Treasury Option Action: light call positioning on the 10-year »

Treasury Option Action:…

SYPR

Sypris Solutions

$1.67

0.09 (5.70%)

10:58
08/14/18
08/14
10:58
08/14/18
10:58
Earnings
Sypris Solutions confirms 2H guidance for revenue of $47M-$51M »

The company confirmed its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Aug

SYPR

Sypris Solutions

$1.67

0.09 (5.70%)

10:57
08/14/18
08/14
10:57
08/14/18
10:57
Earnings
Sypris Solutions reports Q2 EPS 4c, one estimate 0c »

Reports Q2 revenue $23M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Aug

AMD

AMD

$20.18

0.46 (2.33%)

10:50
08/14/18
08/14
10:50
08/14/18
10:50
Options
In-the-money vertical call spread sale in AMD with shares at 10 year highs »

In-the-money vertical…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Aug

  • 12

    Sep

10:50
08/14/18
08/14
10:50
08/14/18
10:50
General news
Treasury Action: curve flatteners have returned »

Treasury Action: curve…

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$283.16

1.03 (0.37%)

10:40
08/14/18
08/14
10:40
08/14/18
10:40
Technical Analysis
Technical Take: SPDR S&P 500 ETF hits session highs after first hour »

The SPDR S&P 500 ETF…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$283.16

1.03 (0.37%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PM

Philip Morris

$82.35

0.49 (0.60%)

10:40
08/14/18
08/14
10:40
08/14/18
10:40
Options
Second day of active trading in Phillip Morris calls as shares tick higher »

Second day of active…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EA

Electronic Arts

$130.53

-0.76 (-0.58%)

10:33
08/14/18
08/14
10:33
08/14/18
10:33
Hot Stocks
Electronic Arts announces departure of Chief Design Officer Patrick Soderlund »

Electronic Arts announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Aug

  • 15

    Aug

  • 04

    Sep

  • 12

    Sep

  • 12

    Sep

  • 13

    Sep

CSCO

Cisco

$43.74

-0.02 (-0.05%)

10:30
08/14/18
08/14
10:30
08/14/18
10:30
Options
Short-term call spreads in Cisco ahead of earnings »

Short-term call spreads…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Aug

  • 29

    Aug

  • 30

    Aug

  • 04

    Sep

  • 12

    Sep

10:30
08/14/18
08/14
10:30
08/14/18
10:30
General news
FX Action: USD-CAD »

FX Action: USD-CAD…

EEFT

Euronet

$94.17

0.29 (0.31%)

10:27
08/14/18
08/14
10:27
08/14/18
10:27
Conference/Events
Euronet management to meet with Needham »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Aug

  • 14

    Aug

  • 14

    Aug

  • 14

    Aug

  • 15

    Aug

  • 16

    Aug

  • 21

    Aug

  • 04

    Sep

  • 12

    Sep

VIPS

Vipshop

$7.79

-1.19 (-13.25%)

10:24
08/14/18
08/14
10:24
08/14/18
10:24
Downgrade
Vipshop rating change  »

Vipshop downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Aug

  • 10

    Sep

ARDS

Aridis Pharmaceuticals

$0.00

(0.00%)

10:22
08/14/18
08/14
10:22
08/14/18
10:22
Syndicate
Breaking Syndicate news story on Aridis Pharmaceuticals »

Aridis Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Aug

NLSN

Nielsen

$25.87

1.25 (5.08%)

10:22
08/14/18
08/14
10:22
08/14/18
10:22
Hot Stocks
Analysts up Nielsen rating as Elliott takes activist stake, plans push for sale »

After jumping yesterday…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

QQQ

Invesco QQQ Trust

$180.13

-0.21 (-0.12%)

10:20
08/14/18
08/14
10:20
08/14/18
10:20
Options
Bearish vertical put spread in Triple Qs may roll protection »

Bearish vertical put…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KO

Coca-Cola

$46.01

0.19 (0.41%)

, PEP

PepsiCo

$112.91

-0.11 (-0.10%)

10:17
08/14/18
08/14
10:17
08/14/18
10:17
Recommendations
Coca-Cola, PepsiCo, Keurig Dr Pepper analyst commentary  »

BodyArmor stake positive…

KO

Coca-Cola

$46.01

0.19 (0.41%)

PEP

PepsiCo

$112.91

-0.11 (-0.10%)

KDP

Keurig Dr Pepper

$23.51

-0.24 (-1.01%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

10:17
08/14/18
08/14
10:17
08/14/18
10:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

10:16
08/14/18
08/14
10:16
08/14/18
10:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HBM

Hudbay Minerals

$4.93

-0.1 (-1.99%)

, ESTA

Establishment Labs

$27.10

(0.00%)

10:16
08/14/18
08/14
10:16
08/14/18
10:16
Initiation
On The Fly: Top five analyst initiations »

Catch up on today's…click here.

HBM

Hudbay Minerals

$4.93

-0.1 (-1.99%)

ESTA

Establishment Labs

$27.10

(0.00%)

YEXT

Yext

$22.84

0.27 (1.20%)

AKBA

Akebia

$8.22

0.4 (5.12%)

REPL

Replimune Group

$17.10

0.01 (0.06%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Aug

  • 16

    Aug

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.